Teradyne (TER) Current Deferred Revenue (2009 - 2026)

Teradyne has reported Current Deferred Revenue for 18 years, with the latest figure at $193.8 million in Q2 2026.

• Current Deferred Revenue for Q2 2026 came in at $193.8 million, up 56.34% year-over-year; the trailing twelve-month figure through Jun 2026 was $193.8 million (up 56.34% YoY), and the FY2025 annual result was $153.1 million, up 42.16% from the prior year.
• Current Deferred Revenue declined to $193.8 million in Q2 2026, from $197.1 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $213.5 million in Q3 2022 and troughed at $99.8 million in Q3 2024.
• A 5-year average of $145.7 million and a median of $140.7 million in 2022 frame the typical range for Current Deferred Revenue.
• The widest annual swing landed in 2023, when Current Deferred Revenue sank 43.02%; it then surged 64.43% in 2026.
• A 5-year view of Current Deferred Revenue shows it stood at $148.3 million in 2022, then tumbled by 32.69% to $99.8 million in 2023, then advanced by 7.92% to $107.7 million in 2024, then surged by 42.16% to $153.1 million in 2025, then gained by 26.59% to $193.8 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $193.8 million in Q2 2026, $197.1 million in Q1 2026, and $153.1 million in Q4 2025.